BONVIVA 150 mg, film-coated tablet tablet
Active ingredients: Ibandronic acid, Ibandronate sodium hydrate
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablettabletorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BONVIVA 150 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC PVDC aluminium de 1 comprimé(s)
- Marketing authorisation holder
- ATNAHS PHARMA UK (ROYAUME-UNI)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 5 Jan 2007
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68419617CIP73716578CIP133400937165785Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ACIDE IBANDRONIQUEcomprimé | 150 mg · un comprimé | FT |
| IBANDRONIQUE (ACIDE), SEL MONOSODIQUE, MONOHYDRATÉcomprimé | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.